About this trial
The DS Prime Taper EV dental implant system was recently launched on the implant market by Dentsply Sirona (York, PA, USA).
Dental implant systems are undergoing rapid evolution, ultimately driven by their broad therapeutic indications. As manufacturers strive to keep up with the demands of a growing market, designs are changing faster than clinical evaluation. This means that the time needed to assess medium- and long-term clinical outcomes before designs change again cannot be met.
Clinicians need to have a "real" analysis of the clinical performance of implants before using them. Therefore, reporting of results is necessary to avoid use in patients without proper practical checks even before the recommended 10- and 15-year follow-up periods.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
All the patients whom received at least one DS Prime Taper implant.
Disqualifiers
When dental implant surgery is contraindicated.
Trial population
Patients receiving DS Prime Taper dental implant in a private dental office.
Trial design
Cohort
Prospective
Treatments tested in this trial
Implant Treatment
DeviceSurgical placement of a DS Prime Taper implant and its posterior prosthesis.
Treatment groups
Trial outcomes
Primary outcomes
Implant Survival Rate
Time of survival of DS Prime Taper dental implant placed
Implant Success Rate
Radiological assessment of Marginal Bone Levels around DS Prime Taper implants in function
Biological and mechanical complications events
All type of complications that may occur during implant survival
Sponsors and contacts
Click on the lead sponsor to view all of their trials.